Astratus is a company headquartered in the United Kingdom.
Develops a rapid antimicrobial susceptibility testing (AST) platform comprising a microcapillary dip-and-test assay cartridge and instrument reader that delivers digitised AST results in under 6 hours for human, veterinary and research laboratories. The system is high-throughput, semi-automated and intended to replace manual, labour-intensive AST methods.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.